The overall OR calculated from the six studies indicates a correlation between the presence of the ACE II genotype and the risk of ROP requiring treatment (fixed effects model [FEM]: OR = 1.21, 95% CI: 1.00 – 1.45, Pcrude = 0.045; Padjusted = 0.314). This evidence concerns the gene ACE and retinopathy of prematurity.